Ferid Murad

Abu Dhabi Stem Cells Center Successfully Manufactures UAE's First CAR-T Cell to Treat an 11-Year Old Leukemia Patient

Retrieved on: 
Monday, September 18, 2023
SKMC, Workforce, GMP, Heart, Center of excellence, Hematopoietic stem cell transplantation, Murad, Neoplasm, Physician, Bone marrow, ABU, Ferid Murad, Research, Cell, CAR, Department of Health (Abu Dhabi), Laboratory, Patient, Good manufacturing practice, Child, Engineering, Immune system, Excellency, Leukemia, Health, Safety, Family, Sheikh Khalifa Medical City, Vaccine, Nursing, Pharmaceutical industry

ABU DHABI, UAE, Sept. 18, 2023 /PRNewswire/ -- Abu Dhabi Stem Cells Center (ADSCC), a PureHealth subsidiary and the largest healthcare platform in the Middle East, has successfully manufactured the UAE's first CAR-T cells to treat an 11-year-old boy with leukemia.

Key Points: 
  • ABU DHABI, UAE, Sept. 18, 2023 /PRNewswire/ -- Abu Dhabi Stem Cells Center (ADSCC), a PureHealth subsidiary and the largest healthcare platform in the Middle East, has successfully manufactured the UAE's first CAR-T cells to treat an 11-year-old boy with leukemia.
  • The child, Murad, was diagnosed with leukemia more than five years ago and went into remission, but unfortunately, the leukemia returned approximately six months ago.
  • The treatment took five weeks, during which Murad was admitted at ADSCC, the only accredited Centre of Excellence in Hematopoietic Stem Cell Transplantation in Abu Dhabi.
  • Physicians withdrew the cells from the patient and genetically modified his immune cells in the laboratory to fight the cancer cells after intravenously injecting them into the patient.

Abu Dhabi Stem Cells Center Successfully Manufactures UAE's First CAR-T Cell to Treat an 11-Year Old Leukemia Patient

Retrieved on: 
Monday, September 18, 2023
SKMC, Workforce, GMP, Heart, Center of excellence, Hematopoietic stem cell transplantation, Murad, Neoplasm, Physician, Bone marrow, ABU, Ferid Murad, Research, Cell, CAR, Department of Health (Abu Dhabi), Laboratory, Patient, Good manufacturing practice, Child, Engineering, Immune system, Excellency, Leukemia, Health, Safety, Family, Sheikh Khalifa Medical City, Vaccine, Nursing, Pharmaceutical industry

ABU DHABI, UAE, Sept. 18, 2023 /PRNewswire/ -- Abu Dhabi Stem Cells Center (ADSCC), a PureHealth subsidiary and the largest healthcare platform in the Middle East, has successfully manufactured the UAE's first CAR-T cells to treat an 11-year-old boy with leukemia.

Key Points: 
  • ABU DHABI, UAE, Sept. 18, 2023 /PRNewswire/ -- Abu Dhabi Stem Cells Center (ADSCC), a PureHealth subsidiary and the largest healthcare platform in the Middle East, has successfully manufactured the UAE's first CAR-T cells to treat an 11-year-old boy with leukemia.
  • The child, Murad, was diagnosed with leukemia more than five years ago and went into remission, but unfortunately, the leukemia returned approximately six months ago.
  • The treatment took five weeks, during which Murad was admitted at ADSCC, the only accredited Centre of Excellence in Hematopoietic Stem Cell Transplantation in Abu Dhabi.
  • Physicians withdrew the cells from the patient and genetically modified his immune cells in the laboratory to fight the cancer cells after intravenously injecting them into the patient.

Nobel Laureate, Dr. Ferid Murad, joins HumanN

Retrieved on: 
Thursday, May 14, 2020
Branches of biology, Chemistry, Physical sciences, Gaseous signaling molecules, Nitrogen cycle, GABAA receptor positive allosteric modulators, NMDA receptor antagonists, Nitric oxide, Ferid Murad, Nitric oxide

Murad, a Nobel Laureate and renowned international nitric oxide authority, jointly discovered nitric oxide as a critical signaling molecule in the cardiovascular system in 1998.

Key Points: 
  • Murad, a Nobel Laureate and renowned international nitric oxide authority, jointly discovered nitric oxide as a critical signaling molecule in the cardiovascular system in 1998.
  • This key discovery is the foundation on which Humann was founded in 2010.
  • Dr. Murad discovered the first biological effects of nitric oxide while at the University of Virginia in the late 1970s.
  • Dr. Ferid Murad, added, "I am delighted to be joining Humann, a company that truly relies on science and I am impressed with Humann's deep commitment to science-based products.